Anti-human TNFSF11 monoclonal antibody, denosumab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1176-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: AMG162
target TNFSF11
alias CD254, hRANKL2, ODF, OPGL, OPTB2, RANKL, sOdf, TNLG6B, TRANCE
gene id Uniprot ID: O14788
host species Human
reactivity Human
iso type Human IgG2 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications Flow Cyt
dilution Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

HEK293 cell line transfected with irrelevant protein (red histogram) and human TNFSF11 protein (blue histogram) were surface stained with Anti-TNFSF11 (denosumab biosimilar)mAb 1ug/ml followed by Alexa 488-conjugated Goat anti-Human IgG secondary antibody.


PRODUCT

  • SKU

    DMS1176-100ug

  • Size

    100ug

  • Price

    $350

1